Table 2.

Variables associated with AWO after 1.5 years of follow-up.

No AWO, n = 64Any AWO, n = 37Univariable Analysis, OR (95% CI)Multivariable Analysis, OR (95% CI)
Age, yrs, mean (SD)45 (8)43 (9)0.97 (0.93–1.03)
Male sex, n (%)36 (56)16 (43)1.65 (0.72–3.76)
BMI, kg/m2, mean (SD)24 (4)25 (4)1.05 (0.95–1.15)
Postgraduate studies, n (%)44 (69)11 (31)0.77 (0.32–1.84)
Blue-collar workers, n (%)18 (28)8 (21)0.78 (0.29–2.10)
BASDAI, mean (SD)33 (20)35 (21)1.00 (0.98–1.02)
BASFI, mean (SD)19 (20)27 (25)1.01 (0.99–1.03)1.01 (0.99–1.03)
Symptom duration, yrs, mean (SD)15 (9)11 (6)0.93 (0.88–0.99)0.94 (0.89–0.99)
Moderate/high-risk AS-WIS score, n (%)22 (35)24 (66)3.52 (1.50–8.24)2.71 (1.04–7.22)
Radiographic sacroiliitis, n (%)37 (58)21 (57)0.87 (0.36–2.13)
HLA-B27+, n (%)38 (59)22 (59)1.01 (0.38–2.60)
Anti-TNF treatment, n (%)40 (63)26 (70)1.23 (0.49–3.07)
  • Values in bold denote variables associated to AWO or with a trend for association (P < 0.10) in univariable analysis. AS-WIS: Ankylosing Spondylitis Work Instability Scale; AWO: adverse work outcomes; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Functional Index; TNF: tumor necrosis factor.